Frontlight ResearchEarly access
Trial site
Hepato-Gastroenterologie HK
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis4 trials
- Crohn's disease1 trial
- Primary biliary cholangitis1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Calliditas Therapeutics Suisse SA1 trial
Running trials
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis1 recruiting
Closed trials
Completed
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026